Search by Drug Name or NDC

    NDC 00131-1810-67 Vimpat 10 mg/mL Details

    Vimpat 10 mg/mL

    Vimpat is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCB, Inc.. The primary component is LACOSAMIDE.

    Product Information

    NDC 00131-1810
    Product ID 0131-1810_a8023ff0-e06c-4d04-ad9f-a60d825c4df5
    Associated GPIs 72600036002020
    GCN Sequence Number 064437
    GCN Sequence Number Description lacosamide VIAL 200MG/20ML INTRAVEN
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14344
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Brand
    Proprietary Name Vimpat
    Proprietary Name Suffix n/a
    Non-Proprietary Name lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name LACOSAMIDE
    Labeler Name UCB, Inc.
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category NDA
    Application Number NDA022254
    Listing Certified Through 2024-12-31

    Package

    NDC 00131-1810-67 (00131181067)

    NDC Package Code 0131-1810-67
    Billing NDC 00131181067
    Package 10 VIAL, GLASS in 1 CARTON (0131-1810-67) / 20 mL in 1 VIAL, GLASS
    Marketing Start Date 2009-05-26
    NDC Exclude Flag N
    Pricing Information N/A